The Mortality Burden of Untreated Aortic Stenosis

医学 内科学 狭窄 死亡率 心脏病学 多元分析 主动脉瓣狭窄 置信区间 审查(临床试验) 病理
作者
Philippe Généreux,Rahul Sharma,Robert J. Cubeddu,LaTayia Aaron,Omar Abdelfattah,Konstantinos Koulogiannis,Leo Marcoff,Mostafa Naguib,Samir Kapadia,Rajendra Makkar,Vinod H. Thourani,Benjamin S. van Boxtel,David J. Cohen,Michael Dobbles,Glenn R. Barnhart,Michelle Kwon,Philippe Pîbarot,Martin B. Leon,Linda D. Gillam
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:82 (22): 2101-2109 被引量:26
标识
DOI:10.1016/j.jacc.2023.09.796
摘要

The American College of Cardiology/American Heart Association guidelines recommend the assessment and grading of severity of aortic stenosis (AS) as mild, moderate, or severe, per echocardiogram, and recommend aortic valve replacement (AVR) when the AS is severe. The authors sought to describe mortality rates across the entire spectrum of untreated AS from a contemporary, large, real-world database. We analyzed a deidentified real-world data set including 1,669,536 echocardiographic reports (1,085,850 patients) from 24 U.S. hospitals (egnite Database, egnite). Patients >18 years of age were classified by diagnosed AS severity. Untreated mortality and treatment rates were examined with Kaplan-Meier (KM) estimates, with results compared using the log-rank test. Multivariate hazards analysis was performed to assess associations with all-cause mortality. Among 595,120 patients with available AS severity assessment, the KM-estimated 4-year unadjusted, untreated, all-cause mortality associated with AS diagnosis of none, mild, mild-to-moderate, moderate, moderate-to-severe, or severe was 13.5% (95% CI: 13.3%-13.7%), 25.0% (95% CI: 23.8%-26.1%), 29.7% (95% CI: 26.8%-32.5%), 33.5% (95% CI: 31.0%-35.8%), 45.7% (95% CI: 37.4%-52.8%), and 44.9% (95% CI: 39.9%-49.6%), respectively. Results were similar when adjusted for informative censoring caused by treatment. KM-estimated 4-year observed treatment rates were 0.2% (95% CI: 0.2%-0.2%), 1.0% (95% CI: 0.7%-1.3%), 4.2% (95% CI: 2.0%-6.3%), 11.4% (95% CI: 9.5%-13.3%), 36.7% (95% CI: 31.8%-41.2%), and 60.7% (95% CI: 58.0%-63.3%), respectively. After adjustment, all degrees of AS severity were associated with increased mortality. Patients with AS have high mortality risk across all levels of untreated AS severity. Aortic valve replacement rates remain low for patients with severe AS, suggesting that more research is needed to understand barriers to diagnosis and appropriate approach and timing for aortic valve replacement.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烟花应助科研通管家采纳,获得10
2秒前
ccm应助科研通管家采纳,获得150
2秒前
GPTea应助科研通管家采纳,获得150
2秒前
丘比特应助科研通管家采纳,获得10
2秒前
星辰大海应助科研通管家采纳,获得10
2秒前
Ava应助科研通管家采纳,获得10
2秒前
炼丹师应助科研通管家采纳,获得20
2秒前
Tourist应助科研通管家采纳,获得10
3秒前
科研通AI6应助科研通管家采纳,获得10
3秒前
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
3秒前
科目三应助科研通管家采纳,获得10
3秒前
一叶知秋应助科研通管家采纳,获得10
3秒前
ccm应助科研通管家采纳,获得10
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
慕青应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
情怀应助科研通管家采纳,获得30
3秒前
李爱国应助科研通管家采纳,获得10
4秒前
传奇3应助科研通管家采纳,获得30
4秒前
4秒前
一叶知秋应助科研通管家采纳,获得10
4秒前
打打应助科研通管家采纳,获得10
4秒前
李健应助科研通管家采纳,获得10
4秒前
英俊的铭应助科研通管家采纳,获得10
4秒前
传奇3应助科研通管家采纳,获得10
4秒前
李爱国应助科研通管家采纳,获得10
4秒前
科研通AI6应助科研通管家采纳,获得10
4秒前
dy1994完成签到,获得积分10
5秒前
科研通AI5应助jy采纳,获得10
7秒前
乡乡发布了新的文献求助10
7秒前
8秒前
负责的烨霖完成签到,获得积分20
8秒前
阿伟完成签到,获得积分10
9秒前
努力向前看完成签到,获得积分10
9秒前
11秒前
14秒前
14秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5134322
求助须知:如何正确求助?哪些是违规求助? 4335087
关于积分的说明 13505951
捐赠科研通 4172482
什么是DOI,文献DOI怎么找? 2287697
邀请新用户注册赠送积分活动 1288658
关于科研通互助平台的介绍 1229444